Anthropic launched Claude Science on June 30, an AI research platform integrating 60+ tools for drug discovery focused on neglected diseases and rare

European life sciences startups are watching closely after Anthropic unveiled a new suite of tools designed to automate scientific research.

The AI drug boom has a long way to go before reaching patients.

Anthropic is launching its own drug development program for neglected diseases that the pharmaceutical industry considers unprofitable. Novartis CEO Vas Narasimhan thinks AI could…

Anthropic launched Claude Science on June 30, an AI research platform integrating 60+ tools for drug discovery focused on neglected diseases and rare

La empresa detrás de Claude busca desarrollar fármacos para afecciones médicas que, según explicó, las biofarmacéuticas tradicionales suelen descartar

Anthropic released Claude Science, a beta multi-agent AI workbench that runs end-to-end research pipelines and checks every citation.